{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:28:57Z","timestamp":1758274137933,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T00:00:00Z","timestamp":1708128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T00:00:00Z","timestamp":1708128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-024-05478-7","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T12:02:13Z","timestamp":1708171333000},"page":"2155-2162","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Serum interleukin-33 and soluble suppression of tumorigenicity 2 in pediatric leukemia with febrile neutropenia"],"prefix":"10.1007","volume":"183","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3279-8435","authenticated-orcid":false,"given":"Merve Cansu","family":"Polat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9307-5674","authenticated-orcid":false,"given":"\u00c7i\u011fdem","family":"S\u00f6nmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5488-2385","authenticated-orcid":false,"given":"Ne\u015fe","family":"Yarali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6857-0681","authenticated-orcid":false,"given":"Nam\u0131k Ya\u015far","family":"\u00d6zbek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,17]]},"reference":[{"issue":"1","key":"5478_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pcl.2014.09.004","volume":"62","author":"D Bhojwani","year":"2015","unstructured":"Bhojwani D, Yang JJ, Pui CH (2015) Biology of Childhood Acute Lymphoblastic Leukemia. Pediatr Clin North Am 62(1):47\u201360. https:\/\/doi.org\/10.1016\/j.pcl.2014.09.004","journal-title":"Pediatr Clin North Am"},{"issue":"2","key":"5478_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3322\/caac.21219","volume":"64","author":"E Ward","year":"2014","unstructured":"Ward E, DeSantis C, Robbins A, Kohler B, Jemal A (2014) Childhood and adolescent cancer statistics. CA Cancer J Clin 64(2):83\u2013103. https:\/\/doi.org\/10.3322\/caac.21219","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"5478_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52(4):56\u201393. https:\/\/doi.org\/10.1093\/cid\/cir073","journal-title":"Clin Infect Dis"},{"key":"5478_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/s0924-8579(00)00239-9","volume":"16","author":"F Crokaert","year":"2000","unstructured":"Crokaert F (2000) Febrile neutropenia in children. Int J Antimicrob Agents 16:173\u2013176. https:\/\/doi.org\/10.1016\/s0924-8579(00)00239-9","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"5478_CR5","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/infdis\/166.2.432","volume":"166","author":"P Riikonen","year":"1992","unstructured":"Riikonen P, Saarinen UM, Mets\u00e4rinne TA, K, Fyhrquist F, Jalanko H, (1992) Cytokine and Acute-Phase Reactant Levels in Serum of Children with Cancer Admitted for Fever and Neutropenia. J Infect Dis 166(2):432\u2013436. https:\/\/doi.org\/10.1093\/infdis\/166.2.432","journal-title":"J Infect Dis"},{"issue":"6","key":"5478_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcla.22147","volume":"31","author":"Y Ebihara","year":"2017","unstructured":"Ebihara Y, Kobayashi K, Ishida A, Maeda T, Takahashi N, Taji Y et al (2017) Diagnostic performance of procalcitonin, presepsin, and reactive protein in patients with hematological malignancies. J Clin Lab Anal 31(6):1\u20137. https:\/\/doi.org\/10.1002\/jcla.22147","journal-title":"J Clin Lab Anal"},{"issue":"12","key":"5478_CR7","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s00277-017-3128-1","volume":"96","author":"CS Michel","year":"2017","unstructured":"Michel CS, Teschner D, Wagner EM, Theobald M, Radsak MP (2017) Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantation. Ann Hematol 96(12):2095\u20132101. https:\/\/doi.org\/10.1007\/s00277-017-3128-1","journal-title":"Ann Hematol"},{"issue":"1\u20132","key":"5478_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s12026-012-8283-9","volume":"52","author":"M Milovanovic","year":"2012","unstructured":"Milovanovic M, Volarevic V, Radosavljevic G, Jovanovic I, Pejnovic N, Arsenijevic N et al (2012) IL-33 \/ ST2 axis in inflammation and immunopathology. Immunol Res 52(1\u20132):89\u201399. https:\/\/doi.org\/10.1007\/s12026-012-8283-9","journal-title":"Immunol Res"},{"key":"5478_CR9","doi-asserted-by":"publisher","unstructured":"Xu H, Turnquist HR, Hoffman R, Billiar TR (2017) Role of the IL-33-ST2 axis in sepsis. Mil Med Res 2(4:3)1\u20139. https:\/\/doi.org\/10.1186\/s40779-017-0115-8","DOI":"10.1186\/s40779-017-0115-8"},{"issue":"6","key":"5478_CR10","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.cytogfr.2015.07.017","volume":"26","author":"M De la Fuente","year":"2015","unstructured":"De la Fuente M, Macdonald TT, Hermoso MA (2015) The IL-33 \/ ST2 axis: Role in health and disease. Cytokine Growth Factor Rev 26(6):615\u2013623. https:\/\/doi.org\/10.1016\/j.cytogfr.2015.07.017","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"5478_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/imr.12619","volume":"281","author":"C Cayrol","year":"2018","unstructured":"Cayrol C, Girard JP (2018) Interleukin- 33 (IL- 33): A nuclear cytokine from the IL- 1 family. Immunol Rev 281(1):154\u2013168. https:\/\/doi.org\/10.1111\/imr.12619","journal-title":"Immunol Rev"},{"issue":"1","key":"5478_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2796.2010.02316.x","volume":"269","author":"M Kurowska","year":"2011","unstructured":"Kurowska M, Hueber A, Stolarski B (2011) Interleukin-33: a novel mediator with a role in distinct disease pathologies. J Intern Med 269(1):29\u201335. https:\/\/doi.org\/10.1111\/j.1365-2796.2010.02316.x","journal-title":"J Intern Med"},{"issue":"6","key":"5478_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nrrheum.2011.53","volume":"7","author":"G Palmer","year":"2011","unstructured":"Palmer G, Gabay C (2011) Interleukin-33 biology with potential insights into human diseases. Nat Rev Rheumatol 7(6):321\u2013329. https:\/\/doi.org\/10.1038\/nrrheum.2011.53","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"5478_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/imm.12174","volume":"141","author":"C Pei","year":"2014","unstructured":"Pei C, Barbour M, Fairlie-Clarke KJ, Allan D, Mu R, Jiang HR (2014) Emerging role of interleukin-33 in autoimmune diseases. Immunology 141(1):9\u201317. https:\/\/doi.org\/10.1111\/imm.12174","journal-title":"Immunology"},{"key":"5478_CR15","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3389\/fimmu.2017.00475","volume":"8","author":"B Griesenauer","year":"2017","unstructured":"Griesenauer B, Paczesny S (2017) The ST2\/IL-33 Axis in Immune Cells during Inflammatory Diseases. Front Immunol 8:475. https:\/\/doi.org\/10.3389\/fimmu.2017.00475","journal-title":"Front Immunol"},{"issue":"3","key":"5478_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1159\/000353476","volume":"131","author":"C Musolino","year":"2014","unstructured":"Musolino C, Allegra A, Profita M, Alonci A, Saitta S, Bonanno A et al (2014) Reduction in IL-33 Plasma Levels Might Be Involved in T Cell Dysregulation in Chronic Lymphocytic Leukemia. Acta Haematol 131(3):165\u2013166. https:\/\/doi.org\/10.1159\/000353476","journal-title":"Acta Haematol"},{"key":"5478_CR17","doi-asserted-by":"publisher","unstructured":"Qin L, Dominguez D, Chen S, Fan J, Long A, Zhang M et al (2016) Exogenous IL-33 overcomes T cell 83 tolerance in murine acute myeloid leukemia. Oncotarget 20;7(38):61069\u201361080.\u00a0https:\/\/doi.org\/10.18632\/oncotarget.11179","DOI":"10.18632\/oncotarget.11179"},{"issue":"6","key":"5478_CR18","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1086\/339215","volume":"34","author":"WT Hughes","year":"2002","unstructured":"Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T et al (2002) 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer. Clin Infect Dis 34(6):730\u2013751. https:\/\/doi.org\/10.1086\/339215","journal-title":"Clin Infect Dis"},{"key":"5478_CR19","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.ajem.2021.09.055","volume":"50","author":"CD Pulcini","year":"2021","unstructured":"Pulcini CD, Lentz S, Saladino RA, Bounds R, Herrington R, Michaels MG et al (2021) Emergency management of fever and neutropenia in children with cancer: A review. Am J Emerg Med 50:693\u2013698. https:\/\/doi.org\/10.1016\/j.ajem.2021.09.055","journal-title":"Am J Emerg Med"},{"issue":"2","key":"5478_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00277-003-0766-2","volume":"8","author":"D Buchheidt","year":"2003","unstructured":"Buchheidt D, B\u00f6hme A, F\u00e4tkenheuer COA, G, Fuhr HG, Heussel G, et al (2003) Diagnosis and treatment of documented infections in neutropenic patients Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 8(2):127\u2013312. https:\/\/doi.org\/10.1007\/s00277-003-0766-2","journal-title":"Ann Hematol"},{"key":"5478_CR21","doi-asserted-by":"publisher","unstructured":"Boccia R, Glaspy J, Crawford J, Aapro M (2022) Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?. Oncologist 5;27(8):625\u201336. https:\/\/doi.org\/10.1093\/oncolo\/oyac074","DOI":"10.1093\/oncolo\/oyac074"},{"issue":"5","key":"5478_CR22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/08880010802106564","volume":"25","author":"S Bakhshi","year":"2008","unstructured":"Bakhshi S, Padmanjali KS, Arya LS (2008) An Analysis of 222 Febrile Neutropenic Episodes. Pediatr Hematol Oncol 25(5):385\u2013392. https:\/\/doi.org\/10.1080\/08880010802106564","journal-title":"Pediatr Hematol Oncol"},{"key":"5478_CR23","doi-asserted-by":"publisher","unstructured":"Giamarellou H, Antoniadou A (2001) Infectious Complications of Febrile Leukopenia. Infect Dis Clin North Am 15(2):457\u201382. https:\/\/doi.org\/10.1016\/s0891-5520(05)70156-2","DOI":"10.1016\/s0891-5520(05)70156-2"},{"issue":"40","key":"5478_CR24","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1086\/427329","volume":"1","author":"C Viscoli","year":"2005","unstructured":"Viscoli C, Varnier O, Machetti M (2005) Infections in Patients with Febrile Neutropenia: Epidemiology, Microbiology and Risk Stratification. Clin Infect Dis 1(40):240\u2013245. https:\/\/doi.org\/10.1086\/427329","journal-title":"Clin Infect Dis"},{"key":"5478_CR25","doi-asserted-by":"publisher","unstructured":"Castagnola E, Fontano V, Caviglia I, Caruso S, Faraci M, Fioredda F et al (2007) A Prospective Study on the Epidemiology of Febrile Episodes during Chemotherapy-Induced Neutropenia in Children with Cancer or after Hemopoietic Stem Cell Transplantation. Clin Infect Dis 15;45(10):1296\u2013304.\u00a0https:\/\/doi.org\/10.1086\/522533","DOI":"10.1086\/522533"},{"key":"5478_CR26","first-page":"168","volume":"49","author":"M Baysallar","year":"2007","unstructured":"Baysallar M, G\u00fc\u00e7l\u00fc A\u00dc, \u015eenses Z, Kaptan K, Ataergin S (2007) Ba\u015fustao\u011flu AC (2007) Febril n\u00f6tropenik hastalar\u0131n kan k\u00fclt\u00fcrlerinde bakteriyel spektrum ve antimikrobiyal duyarl\u0131l\u0131k profili. G\u00fclhane T\u0131p Dergisi 49:168\u2013172","journal-title":"G\u00fclhane T\u0131p Dergisi"},{"issue":"3","key":"5478_CR27","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jcv.2009.11.026","volume":"47","author":"A Lindblom","year":"2010","unstructured":"Lindblom A, Bhadri V, S\u00f6derh\u00e4ll S, Ohrmalm L, Wong M, Norbeck O et al (2010) Respiratory viruses, a common microbiological finding in neutropenic children with fever. J Clin Virol 47(3):234\u2013237. https:\/\/doi.org\/10.1016\/j.jcv.2009.11.026","journal-title":"J Clin Virol"},{"issue":"3","key":"5478_CR28","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/clinchem\/47.3.426","volume":"47","author":"HK Meier-ewert","year":"2001","unstructured":"Meier-ewert HK, Ridker PM, Rifai N, Price N, Dinges DF, Mullington JM (2001) Absence of Diurnal Variation of C-Reactive Protein Concentrations in Healthy Human Subjects. Clin Chem 47(3):426\u2013430","journal-title":"Clin Chem"},{"issue":"14","key":"5478_CR29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/1471-2407-14-198","volume":"18","author":"D Lu","year":"2014","unstructured":"Lu D, Zhou X, Yao L, Liu CG, Ma W, Jin F et al (2014) Serum soluble ST2 is associated with ER-positive breast cancer. BMC Cancer 18(14):198. https:\/\/doi.org\/10.1186\/1471-2407-14-198","journal-title":"BMC Cancer"},{"key":"5478_CR30","doi-asserted-by":"publisher","unstructured":"Vu D, Peck AJ, Nichols WG, Varley C, Englund JA, Corey L et al (2007) Safety and Tolerability of Oseltamivir Prophylaxis in Hematopoietic Stem Cell Transplant Recipients: A Retrospective Case-Control Study. Clin Infect Dis 15;45(2):187\u201393.\u00a0https:\/\/doi.org\/10.1086\/518985","DOI":"10.1086\/518985"},{"issue":"4","key":"5478_CR31","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.7314\/apjcp.2013.14.4.2563","volume":"14","author":"L Hu","year":"2013","unstructured":"Hu L, Fu Y, Zhang D, Zhang J (2013) Serum IL-33 as a Diagnostic and Prognostic Marker in Non- small Cell Lung Cancer. Asian Pac J Cancer Prev 14(4):2563\u20132566. https:\/\/doi.org\/10.7314\/apjcp.2013.14.4.2563","journal-title":"Asian Pac J Cancer Prev"},{"issue":"12","key":"5478_CR32","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1007\/s10620-011-1760-5","volume":"56","author":"P Sun","year":"2011","unstructured":"Sun P, Ben Q, Tu S, Qi X, Wu Y (2011) Serum Interleukin-33 Levels in Patients with Gastric Cancer. Dig Dis Sci 56(12):3596\u20133601. https:\/\/doi.org\/10.1007\/s10620-011-1760-5","journal-title":"Dig Dis Sci"},{"issue":"4","key":"5478_CR33","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s00134-010-1773-0","volume":"36","author":"JJ Hoogerwerf","year":"2010","unstructured":"Hoogerwerf JJ, Tanck MWT, van Zoelen MAD, Wittebole X, Laterre PF, van der Poll T (2010) Soluble ST2 plasma concentrations predict mortality in severe sepsis. Intensive Care Med 36(4):630\u2013637. https:\/\/doi.org\/10.1007\/s00134-010-1773-0","journal-title":"Intensive Care Med"},{"issue":"5","key":"5478_CR34","doi-asserted-by":"publisher","first-page":"751","DOI":"10.7754\/clin.lab.2014.141013","volume":"62","author":"F \u00c7ekmez","year":"2016","unstructured":"\u00c7ekmez F, Fidanci MK, Ayar G, Saldir M, Karaoglu A, G\u00fcnd\u00fcz RC et al (2016) Diagnostic Value of Upar, IL-33, and ST2 Levels in Childhood Sepsis. Clin Lab 62(5):751\u2013755. https:\/\/doi.org\/10.7754\/clin.lab.2014.141013","journal-title":"Clin Lab"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-024-05478-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-024-05478-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-024-05478-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T04:21:40Z","timestamp":1713759700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-024-05478-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,17]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["5478"],"URL":"https:\/\/doi.org\/10.1007\/s00431-024-05478-7","relation":{},"ISSN":["1432-1076"],"issn-type":[{"type":"electronic","value":"1432-1076"}],"subject":[],"published":{"date-parts":[[2024,2,17]]},"assertion":[{"value":"16 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent form was obtained from all participants and their parents about the study. All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments. The study described has been carried out in accordance with abovementioned standards and has been approved by the institutional ethics committee of Ankara Child Health and Diseases Hematology and Oncology Training and Research Hospital, University of Health Sciences (E-2017\u2013010).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}